The main health authorities of United States recommended a “pause” in the use of the vaccine against Covid-19 by Johnson & Johnson “As a precaution” while investigating whether it produces blood clots, Said a regulator on Tuesday.
The US Food and Drug Administration and the Centers for Disease Control and Prevention are evaluating the “potential significance” of six reported cases of infrequent blood clots in patients who received the injection, the former tweeted. “Until this process is complete, we recommend this pause,” he said.
Read also: They endorse Johnson & Johnson vaccine application against Covid-19 in pregnant women
“Until this process is complete, we recommend this pause,” he said.
The regulator has reported that by Monday more than 6.8 million doses of the vaccine of Johnson & Johnson in the United States.
“The CDC and the FDA are reviewing data from 6 cases reported in the United States of a rare and severe type of blood clot produced in individuals after receiving the vaccine. At this time, these adverse events appear to be extremely rare,” he said. write the FDA on Twitter.
The agency has stated that it calls for this interruption to allow health care providers to get “the only treatment required against this type of blood clot.”
The CDC will convene an advisory committee Wednesday “to further review these cases and assess their potential importance. The FDA will review this analysis as it also investigates these cases.”
Read also: J&J is ordered to take over a plant that ruined 15 million vaccines in the US
The statement came days after the drug regulator of the European union say he is also reviewing possible cases of blood clots in people who received the Johnson & Johnson injection.
hm